Feb. 24 at 11:49 PM
$HIMS I'm buying more and more as the stock falls.
Haters will keep focusing on GLP-1 while we capture people between 18-40 via peptides, sexual health, custom supplements, blood and cancer testing etc.
Imagine thinking that FDA can stop platforms selling compound pills. Losers will focus on that, missing the
$500B opportunity ahed of
$HIMS mostly due to changing cultural/gender trends and innovations in healthcare.
Basically everybody will want to live forever and look jacked without any effort. How the H are you gonna get that? With companies like
$HIMS ofc.
Let the haters buy
$WMT at 45x earnings. I know where my money will fare better.